is compounded tirzepatide being banned Impurity in Some 'Potentially Dangerous,' Eli Lilly Warns FDA Ban on Compounded GLP-1

DECLARATIONS Authors contributions Developed the model, ran simulations and analyses, interpreted the findings, and contributed to the writing and editing of the manuscript: Cruikshank A, Reed MC, Nijhout HF Availability of data and materials Computer models and codes used in this paper can be obtained from the authors by request

The state alleged that the clinic injected patients with research-grade semaglutide and tirzepatide while marketing the injections as pharmaceutical-grade GLP-1 weight-loss drugs

Women using oral contraceptives should use a non-oral contraceptive method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase, as tirzepatide may reduce oral contraceptive effectiveness

BMI 2526.9 is below FDA label thresholds and prescribed at the provider's discretion